pharmaphorum

JANUARY 6, 2023

From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables life sciences teams to collaborate efficiently and effectively in 2023. Safety will create a single source of truth for content management.

Safety 111

Safety Management Patients Training 111

PharmaTech

SEPTEMBER 19, 2023

Maik Jornitz, Principal Consultant, BioProcess Resources LLC, discusses the definition of patient safety and how to implement new technologies into upgraded facilities.

Safety 98

Safety Patients Consulting FDA 98

MedCity News

OCTOBER 11, 2023

He argued that throwing other professionals into physicians’ roles will have poor ramifications of patient safety. American Medical Association President Dr. Jesse Ehrenfeld said this is a “terrible idea.” In his view, the industry should focus on uplifting strong interprofessional care teams.

Physicians 299

Physicians Safety Medical Healthcare 299

Pharma Pathway

JANUARY 24, 2023

Hetero Labs Limited-Walk-In Interviews for Quality Control/ Quality Assurance/ Engineering/ Safety -EHS On 29th Jan’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Engineering 74

Engineering Safety Pharmaceutical Manufacturing 74

European Pharmaceutical Review

MARCH 27, 2024

percent from 2023 to 2032, according to the research. For example, in 2023, Lonza Group launched several new solutions for endotoxin and pyrogen testing, the report highlighted. However, due to the importance of pyrogen testing for the safety of pharmaceutical products , the report stated that this will help to drive market growth.

Safety 94

Safety Marketing Food and Drug Administration Pharmaceutical 94

European Pharmaceutical Review

JUNE 30, 2023

The power of rapid methods for fungal ID By leveraging rapid identification techniques, pharmaceutical facilities can enhance their ability to detect and mitigate fungal contamination, safeguarding product quality and patient safety. The post In Depth Focus QA/QC Microbiology/RMM 2023 appeared first on European Pharmaceutical Review.

Safety 105

Safety Pharmaceutical Patients 105

European Pharmaceutical Review

OCTOBER 19, 2023

These findings presented at the 2023 European AIDS Conference (EACS 2023) were based on the ongoing Bictegravir Single Tablet Regimen (BICSTaR) study. First paediatric EC approval of HIV drug The post EACS 2023: Gilead shares real-world evidence for Biktarvy® appeared first on European Pharmaceutical Review.

Safety 104

Safety Physicians Food Medical 104

European Pharmaceutical Review

MAY 29, 2023

A neurosteroid drug was one of two medicines recommended for approval at the Committee for Medicinal Products for Human Use (CHMP) ’s May 2023 meeting. This outcome was based on trial results, which compared the effectiveness and safety of Adakveo with placebo in patients who had previously had painful crises leading to a healthcare visit.

Medicine 98

Medicine Marketing Leads Safety 98

European Pharmaceutical Review

NOVEMBER 6, 2023

The Phase III data suggests that] IZERVAY is an effective and safe treatment option for patients with geographic atrophy” “The safety profile over two years was consistent with year 1, with no new safety signals identified. Astellas to accelerate ocular disease treatments with $5.9

Food and Drug Administration 101

Food and Drug Administration Safety Food Patients 101

European Pharmaceutical Review

JANUARY 10, 2023

Clarivate Plc has released its Drugs to Watch 2023 report — among 70 of the drugs highlighted, including potential blockbuster drugs, the majority were revealed to be personalised medicines. The report offers predictive analysis of drugs entering the market or launching key indications in 2023. Drug development in 2023 and beyond.

Food and Drug Administration 98

Food and Drug Administration FDA Food Medicine 98

European Pharmaceutical Review

FEBRUARY 7, 2023

A wave of important legislative changes is anticipated in the EU in 2023 making this year one of the biggest for the EU regulatory landscape governing the life sciences industry in recent times. As a key priority action under the ACT EU initiative, EU regulators plan to establish a multi-stakeholder platform (MSP) in 2023.

Medical 117

Medical Government Marketing Medicine 117

Pharma Pathway

FEBRUARY 4, 2023

On 6th Feb’ 2023 Job Description Walk-In Interviews for B.Sc On 6th Feb’ 2023 @ Aurobindo Pharma Department: Production Qualification: B.Sc Chemistry Experience: Freshers 2020 to 2022 Passouts Gender: Male Only Location: Hyderabad Date: 6th Feb’ 2023 Time: 09:00 AM Venue Details: VLR Facilitators Pvt.

Pharma 87

Pharma Safety 87

Pharma Pathway

FEBRUARY 3, 2023

Jubilant Ingrevia Limited-Walk-In Interviews for Production Chemist On 4th Feb’ 2023 Job Description Walk-In Interviews for Production Chemist On 4th Feb’ 2023 @ Jubilant Ingrevia Limited Position: Production Chemist Qualification: B.Sc -Chemistry/ Diploma- Chemical Experience: 03 to 06 years Experience of reaction, autoclave, hydrogenation, (..)

Safety 85

Safety Pharma 85

PharmaTech

FEBRUARY 21, 2024

FDA's Drug Safety Priorities FY23 describes the center’s key safety programs and activities involved in promoting and protecting public health.

Safety 52

Safety FDA 52

Pharma Pathway

JANUARY 25, 2023

Cipla Limited – Walk-In Drive for Multiple positions On 29th Jan’ 2023 Job Description Company Profile Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression.

Manufacturing 87

Manufacturing Safety Pharma Medicine 87

Pharma Pathway

JANUARY 13, 2023

Novick Biosciences- Walk-In Interview for FRD/ Analytical On 14th to 30th Jan’ 2023. Walk-In Interview for FRD/ Analytical On 14th to 30th Jan’ 2023 @ Novick Biosciences. Date : 14th to 30th Jan’ 2023. Novick Biosciences- Walk-In Interview for FRD/ Analytical On 14th to 30th Jan’ 2023.

Recruitment 83

Recruitment Safety Leads Pharma 83

Pharma Pathway

FEBRUARY 3, 2023

APL Health Care (Aurobindo )-Walk-In Interviews for IPQA/ Microbiology On 4th Feb’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). As part of Covid-19 safety measures, candidates are requested to sanitize their hands at the entrance, Maintain social distance and ware face mask before entering the venue. •As

Pharmaceutical manufacturing 86

Pharmaceutical manufacturing Pharma Education Safety 86

Pharma Pathway

FEBRUARY 11, 2023

Cipla Limited – Walk-In Drive for Production-Formulations/ API/ Sterile Manufacturing/ Quality On 12th Feb’ 2023 Job Description Company Profile Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India.

Manufacturing 88

Manufacturing Safety Pharma Medicine 88

PM360

SEPTEMBER 21, 2023

Jeff Casberg, MS, RPh, Senior Vice President of Clinical Pharmacy at IPD Analytics, a managed care and pharmaceutical consultancy, highlighted a wide range of 2023 key events that will affect managed care professionals by the end of the year. This product is expected to have three generic launches in 2023.

Management 105

Management Manufacturing Sales Competition 105

Pharma Pathway

JANUARY 30, 2023

Ind-Swift Laboratories Ltd-Walk-In Interviews for Production On 5th Feb’ 2023 Job Description Ind-Swift Laboratories Ltd. As part of Covid-19 safety measures, candidates are requested to sanitize their hands at the entrance, Maintain social distance and ware face mask before entering the venue. •As

Manufacturing 82

Manufacturing Safety Marketing Pharma 82

Pharma Pathway

FEBRUARY 27, 2023

Aurobindo Pharma-Walk-In Interviews for Production/ Quality Control/ Packing On 5th Mar’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). Date: 5th Mar’ 2023 Venue Details: Aurobindo Pharma Ltd, Unit-XV, JN Pharma City, Parawada, Visakhapatnam Dist , A.P.

Pharma 83

Pharma Pharmaceutical manufacturing Safety Manufacturing 83

Pharma Pathway

JANUARY 27, 2023

Aurobindo Pharma-Walk-In Interviews for Quality Assurance/ Quality Control On 28th Jan’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). Date : 28th Jan’ 2023 Time: 09:00 AM to 02:00 AM Venue: APL Health Care -Unit IV, SEZ Menakur, Naiduepta, AP. •

Pharma 84

Pharma Pharmaceutical manufacturing Education Safety 84

Pharma Pathway

FEBRUARY 23, 2023

Ltd- Walk-In Interview for QC/ QA/ Production/ Production Operators On 26th Feb’ 2023 Job Description Walk-In Interview for QC/ QA/ Production/ Production Operators On 26th Feb’ 2023 @ Apex Laboratories Pvt. Ltd- Walk-In Interview for QC/ QA/ Production/ Production Operators On 26th Feb’ 2023

Safety 82

Safety Pharma 82

Pharma Pathway

FEBRUARY 17, 2023

Cipla Limited – Walk-In Drive for Production- OSD On 19th Feb’ 2023 Job Description Company Profile Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Chemistry Experience: 01 to 04 years Location: Pan India Date: 19th Feb’ 2023 Time: 09:00 AM to 04:00 PM Venue: Hotel The Aures, P.O

Safety 79

Safety Pharma Manufacturing Medicine 79

pharmaphorum

DECEMBER 22, 2022

As this collective body of experience continues to proliferate, 2023 will see additional FDA guidance. In 2023, expect to see AI innovations improve enrolment agility and, most importantly, the patient experience in a clinical trial. Beyond 2023 – the Sovereign Patient ID. References.

FDA 97

FDA Patients Electronics Medical 97

Pharma Pathway

FEBRUARY 6, 2023

On 8th Feb’ 2023 Job Description Walk-In Interviews for B.Sc On 8th Feb’ 2023 @ Aurobindo Pharma Department: Production Qualification: B.Sc Chemistry Experience: Freshers 2020 to 2022 Passouts Gender: Male Only Location: Hyderabad Date: 8th Feb’ 2023 Time: 09:00 AM Venue Details: VLR Facilitators Pvt. On 8th Feb’ 2023

Pharma 74

Pharma Safety 74

Pharma Pathway

JANUARY 6, 2023

Ltd- Openings for Quality Control/ Quality Assurance/ Production On 7th & 8th Jan’ 2023. Date: 7th & 8th Jan’ 2023. As part of Covid-19 safety measures, candidates are requested to sanitize their hands at the entrance, Maintain social distance and ware face mask before entering the venue. Job Description.

Safety 79

Safety Pharmaceutical Pharma 79

Pharma Pathway

FEBRUARY 15, 2023

As part of Covid-19 safety measures, candidates are requested to sanitize their hands at the entrance, Maintain social distance and ware face mask before entering the venue. Alkem Laboratories Ltd -Walk-In Interviews for Production/ QA/ QC/ Warehouse/ Engineering On 18th Feb’ 2023

Engineering 73

Engineering Safety Manufacturing Pharma 73

Pharma Pathway

JANUARY 3, 2023

Aurobindo Pharma-Walk-In Interviews for Quality Assurance/ Quality Control On 7th Jan’ 2023. Date : 7th Jan’ 2023. As part of Covid-19 safety measures, candidates are requested to sanitize their hands at the entrance, Maintain social distance and ware face mask before entering the venue. •As Job Description.

Pharma 75

Pharma Pharmaceutical manufacturing Manufacturing Education 75

Pharma Pathway

JANUARY 26, 2023

As part of Covid-19 safety measures, candidates are requested to sanitize their hands at the entrance, Maintain social distance and ware face mask before entering the venue. Annora Pharma -Walk-In Interview for Freshers & Experienced in Production-Mfg/ Packing On 27th Jan’ 2023 No 261 Plot No. No 261 Plot No.

Pharma 71

Pharma Safety 71

European Pharmaceutical Review

OCTOBER 11, 2023

Evidence released in July 2023 showed that the treatment met its clinical endpoints in the Phase III study. The safety profile of OCREVUS subcutaneous injection was consistent with the established safety profile of OCREVUS IV infusion. No new safety signals were detected for OCREVUS subcutaneous injection, according to Roche.

Safety 111

Safety Patients Medical Pharmaceutical 111

Pharmaceutical Technology

MARCH 28, 2023

5 adapted bivalent Covid-19 vaccine, the company has forecasted a slump in sales for 2023 as Covid-19 vaccine demand falls. Covid-19 vaccine-related revenue is predicted to drop from an estimated $17.1bn in 2022 to $5bn in 2023. In February 2023, BioNTech and Pfizer initiated a Phase I/II clinical trial in its shingles programme.

Sales 110

Sales Safety Marketing 110

Pharma Pathway

JANUARY 4, 2023

Ltd-Walk-In Interview for freshers & experienced in Production On 6th Jan’ 2023. Responsible for carrying out all the production activities pertaining to his section in the shift following the standard operating procedures and safety norms. Walk-In Date: 6th Jan’ 2023. Neuland Laboratories Pvt. Job Description.

Safety 59

Safety Manufacturing Training Pharma 59

European Pharmaceutical Review

MAY 2, 2024

It summarises the MHRA’s view on the UK government’s white paper on AI regulation published in 2023. The Medicines and Healthcare products Regulatory Agency (MHRA) has published a policy paper on its strategic approach to artificial intelligence (AI).

Safety 115

Safety Medicine Government Medical 115

Pharma Pathway

FEBRUARY 22, 2023

Ltd-Walk-In Drive for B.Sc/ B.Com/ BA Freshers On 24th Feb’ 2023 Job Description Walk-In Drive for B.Sc/ B.Com/ BA Freshers On 24th Feb’ 2023 @ MSN Laboratories Pvt. Ltd-Walk-In Drive for B.Sc/ B.Com/ BA Freshers On 24th Feb’ 2023 MSN Laboratories Pvt.

Safety 56

Safety Pharma 56

European Pharmaceutical Review

JUNE 27, 2023

With Fast Track designation, AC Immune SA “remain firmly on track to report additional interim safety and immunogenicity data later this year, and for the crucial interim readout of Abeta-PET imaging data in AD in the first half of next year,” Dr Johannes Streffer, Chief Medical Officer of AC Immune SA responded.

Food and Drug Administration 105

Food and Drug Administration Safety FDA Food 105

European Pharmaceutical Review

JANUARY 25, 2024

Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. We note the Commission has not conducted an assessment on the impact of removing paper leaflets on patient safety. percent as EU average with some Member States as high as 25 percent).

Healthcare 98

Healthcare Healthcare Safety Electronics 98